- 专利标题： GPR120 agonists for the treatment of type II diabetes
-
申请号： US14200108申请日： 2014-03-07
-
公开(公告)号： US10118922B2公开(公告)日： 2018-11-06
- 发明人: Zhihua Sui , Chaozhong Cai , Xuqing Zhang
- 申请人： Janssen Pharmaceutica NV
- 申请人地址： BE Beerse
- 专利权人： JANSSEN PHARMACEUTICA NV
- 当前专利权人： JANSSEN PHARMACEUTICA NV
- 当前专利权人地址： BE Beerse
- 代理机构： Porzio, Bromberg & Newman P.C.
- 主分类号： C07D417/12
- IPC分类号： C07D417/12 ; C07D275/02 ; C07D275/03 ; C07D333/16 ; C07D409/04 ; C07D417/04 ; C07D333/32 ; C07D275/00
摘要：
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) and Formula (II) as follows: wherein Y, R1, G, and Q are defined herein; and wherein R11, R21, R41, RB1 and G1, are defined herein.
公开/授权文献
- US20140275179A1 GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES 公开/授权日：2014-09-18
信息查询
